PFAS and Emerging Contaminants

On June 24, 2026, plaintiffs United States of America and State of West Virginia filed a Complaint and lodged a proposed Consent Decree (“US Consent Decree”) with the Chemours Company and Chemours Company FC, LLC regarding PFAS at three major operating fluorochemical facilities: Washington Works, West Virginia; Fayetteville Works, North Carolina; and Chambers Works, New

On July 2, 2026, the Pennsylvania Department of Environmental Protection (DEP) announced proposed updates to its biosolids beneficial use general permits, introducing PFAS monitoring and land application limits in draft permits PAG-07 (Beneficial Use of Exceptional Quality Biosolids) and PAG-08 (Beneficial Use of Biosolids).  The two draft permits are available at the links at

On August 7, 2026, the U.S. District Court for the District of New Jersey approved the Judicial Consent Orders (“JCOs”) with 3M and the DuPont Entities (EIDP, Inc., Corteva, Inc., DuPont de Nemours Inc., DuPont Specialty Products USA, LLC, The Chemours Company, and The Chemours Company FC, LLC) which resolve NJDEP’s state-wide PFAS claims against

Minnesota continues refining its statutory restrictions on intentionally added PFAS in products (known as  Amara’s Law) as the state’s deadline for the statute’s reporting requirements approaches.  In early June 2026, an amendment to Amara’s Law was enacted that excludes products that contain intentionally added PFAS made before July 1, 2023 from the statute’s reporting requirement. 

U.S. EPA is withdrawing its proposed rule to list nine PFAS as RCRA hazardous constituents.  U.S.EPA announced the withdrawal in the Federal Register on May 8, 2026.  In announcing the withdrawal, U.S.EPA stated the proposed rule is not necessary since “existing regulations provide the tools to develop protective permit conditions, when necessary, without the